Improve balance with virtual reality
- Trial ID
- NCT07274514
- Official Title
- Effects of Immersive Virtual Reality on Balance of Parkinson's Disease
- Goal
- Improve balance with virtual reality
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Instituto de Investigación Sanitaria Aragón
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- Parkinson Disease (PD), Immersive Virtual Reality, Physical Therapy
- Interventions
- Immersive Virtual Reality Program, Standard Rehabilitation Program
Plain-Language Summary
Aiming to improve balance and reduce instability in people with Parkinson's, the trial tests whether immersive virtual reality training can strengthen postural control and walking in a safe, controlled setting. Participants wear a head-mounted VR system that places them in realistic scenes that challenge stance, weight shifts, and stepping while giving real-time visual feedback, and this program is compared to a standard rehabilitation program; because it is a therapy and not a drug, it does not change how levodopa works. Because VR can cause dizziness or nausea, the study excludes people with severe simulator sickness or major visual or hearing problems, and also excludes those with musculoskeletal limits to standing, recent moderate or severe depression, or impulse control disorders. They are looking for people aged 55 to 90 with neurologist-confirmed Parkinson's, Hoehn and Yahr stage 1 to 4, a Mini Mental State Exam score of 24 or higher, and the ability to stand without help for at least 20 minutes.
Locations
- Asociación de Parkinson de Aragón, Zaragoza, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Immersive Virtual Reality Program. Aiming to improve balance and reduce instability in people with Parkinson's, the trial tests whether immersive virtual reality training can strengthen postural control and walking in a safe, controlled setting. Participants wear a head-mounted VR system that places them in realistic scenes that challenge stance, weight shifts, and stepping while giving real-time visual feedback, and this program is compared to a standard rehabilitation program; because it is a therapy and not a drug, it does not change how levodopa works. Because VR can cause dizziness or nausea, the study excludes people with severe simulator sickness or major visual or hearing problems, and also excludes those with musculoskeletal limits to standing, recent moderate or severe depression, or impulse control disorders. They are looking for people aged 55 to 90 with neurologist-confirmed Parkinson's, Hoehn and Yahr stage 1 to 4, a Mini Mental State Exam score of 24 or higher, and the ability to stand without help for at least 20 minutes.
- Who can participate?
- Participants must be between 55 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.